logo
Select company
Select metric
-362.47%Return on Equity
VS
Market
4
Sector
11
Industry
12
History
3
$ 0.51Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 11.44M$ -41.45M-362.47%
3/31/2025$ 15.12M$ -43.13M-285.31%
12/31/2024$ 7.35M$ -53.36M-725.74%
9/30/2024$ 38.13M$ -27.76M-72.8%
6/30/2024$ 44.08M$ -26.31M-59.69%
3/31/2024$ 44.87M$ -23.6M-52.59%
12/31/2023$ 49.38M$ -16.78M-33.98%
9/30/2023$ 56.43M$ -10.47M-18.56%
6/30/2023$ 59.26M$ -4.37M-7.37%
3/31/2023$ 59.94M$ 6.52M10.88%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) ROE stands at -15%.
  • Over the past 5 years, PROPHASE LABS INC's average ROE has been -75.31%.
  • The median ROE for PROPHASE LABS INC during this period was -12.98%
  • PROPHASE LABS INC reached its highest ROE over the past 5 years at 46.37%.
  • The lowest ROE recorded by PROPHASE LABS INC in the same timeframe -725.74%

PROPHASE LABS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
BNBX : APPLIED DNA SCIENCES INC -929.6%INBS : INTELLIGENT BIO SOLUTIONS INC -352.75%TNON : TENON MEDICAL INC -188.53%TRAW : TRAWS PHARMA INC 1064.03%TXMD : THERAPEUTICSMD INC -1.68%LGVN : LONGEVERON INC -147.66%BOLT : BOLT BIOTHERAPEUTICS INC -130.56%LPCN : LIPOCINE INC -26.31%CYCN : CYCLERION THERAPEUTICS INC -22.71%XAIR : BEYOND AIR INC -424.25%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for PROPHASE LABS INC is calculated as follows: Net Inc. Cmn. [ $ -1.61M ] / Equity [ $ 10.76M ]
(=) ROE [ -15% ]

PRPH - Return on Equity, Last 5 years

-725.74%

Minimum

Dec 31, 2024

46.37%

Maximum

Sep 30, 2022

-75.31%

Average

-12.98%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%